The document discusses entrepreneurial challenges in the Indian pharmaceutical sector. It outlines several key challenges including: raising capital, inconsistent government policies, regulatory hurdles, pricing controls that limit profits, and underinvestment in research and development due to the high costs. Quality management and compliance with global standards are also major challenges, as some Indian plants have been banned by the FDA for not meeting good manufacturing practices. The effects of new product patents, which prevent generic manufacturing during the patent period, threaten the supply of low-cost drugs in India and other dependent countries.
Introduction Indian Pharmaceutical market, SWOT analysis, PEST Analysis, Timeline analysis of Sun Pharma, Glaxo Smith Kline, Mankind, CIPLA and Zydus Cadila.
Cipla’s- Financial Growth in Pandemic: A Statistical AnalysisRuhilaNoor
This study is performed to understand the company's financial growth in terms of revenue (income), employee cost, consumption of materials, and total expenditure. The study also dives into the pre-post covid-19 statistical analysis of its revenue and profit/loss. This research shows that the company's revenue, expenses, and profit have increased in the last 50 quarters. The company incurred loss in only one quarter; however, the profit curve has seen many ups and downs but a marginal increase in the mean profit. This study reveals that the expenditures done by Cipla Ltd. under various heads are statistically different from each other. This research also shows that the company’s revenue has increased significantly after the covid-19 outbreak.
The study predicts the revenue and profit/loss for Cipla Ltd. for the next three quarters. The study is an excellent statistical analysis of financial statements of Cipla Ltd. and can be further improved with more data and predictive models.
A descriptive research paper about the Foreign Direct Investment (FDI) in the Indian Pharmaceutical Industry.
It is a descriptive study on the history of FDI especially in the Indian Pharmaceutical Industry, as well as providing a SWOT Analysis, as well as information on the current market leaders and investors.
Also, the effect of government policies and recent financial changes are mentioned in the presentation
Introduction Indian Pharmaceutical market, SWOT analysis, PEST Analysis, Timeline analysis of Sun Pharma, Glaxo Smith Kline, Mankind, CIPLA and Zydus Cadila.
Cipla’s- Financial Growth in Pandemic: A Statistical AnalysisRuhilaNoor
This study is performed to understand the company's financial growth in terms of revenue (income), employee cost, consumption of materials, and total expenditure. The study also dives into the pre-post covid-19 statistical analysis of its revenue and profit/loss. This research shows that the company's revenue, expenses, and profit have increased in the last 50 quarters. The company incurred loss in only one quarter; however, the profit curve has seen many ups and downs but a marginal increase in the mean profit. This study reveals that the expenditures done by Cipla Ltd. under various heads are statistically different from each other. This research also shows that the company’s revenue has increased significantly after the covid-19 outbreak.
The study predicts the revenue and profit/loss for Cipla Ltd. for the next three quarters. The study is an excellent statistical analysis of financial statements of Cipla Ltd. and can be further improved with more data and predictive models.
A descriptive research paper about the Foreign Direct Investment (FDI) in the Indian Pharmaceutical Industry.
It is a descriptive study on the history of FDI especially in the Indian Pharmaceutical Industry, as well as providing a SWOT Analysis, as well as information on the current market leaders and investors.
Also, the effect of government policies and recent financial changes are mentioned in the presentation
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...sridivyaannavarapu
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
Present Status and Scope of Pharmaceutical industry in IndiaMadhuraNewrekar
The Indian pharmaceutical industry came into existence in 1901, when Bengal Chemical & Pharmaceutical Company started its maiden operation in Calcutta.
The next few decades saw the pharmaceutical industry moving through several phases, largely in accordance with government policies. The development, present status and scope of pharmaceutical industry in India.
Writekraft Research and Publications LLP was initially formed, informally, in 2006 by a group of scholars to help fellow students. Gradually, with several dissertations, thesis and assignments receiving acclaim and a good grade, Writekraft was officially founded in 2011 . Since its establishment, Writekraft Research & Publications LLP is Guiding and Mentoring PhD Scholars.
Our Mission
“To provide breakthrough research works to our clients through Perseverant efforts towards creativity and innovation”.
Vision
Writekraft endeavours to be the leading global research and publications company that will fulfil all research needs of our clients. We will achieve this vision through:
• Analyzing every customer’s aims, objectives and purpose of research
• Using advanced and latest tools and technique of research and analysis
• Coordinating and including their own ideas and knowledge
• Providing the desired inferences and results of the research
In the past decade, we have successfully assisted students from various universities in India and globally. We at Writekraft Research & Publications LLP head office in Kanpur, India are most trusted and professional Research, Writing, Guidance and Publication Service Provider for PhD. Our services meet all your PhD Admissions, Thesis Preparation and Research Paper Publication needs with highest regards for the quality you prefer.
Writekraft Research and Publications LLP was initially formed, informally, in 2006 by a group of scholars to help fellow students. Gradually, with several dissertations, thesis and assignments receiving acclaim and a good grade, Writekraft was officially founded in 2011 . Since its establishment, Writekraft Research & Publications LLP is Guiding and Mentoring PhD Scholars.
Our Mission
“To provide breakthrough research works to our clients through Perseverant efforts towards creativity and innovation”.
Vision
Writekraft endeavours to be the leading global research and publications company that will fulfil all research needs of our clients. We will achieve this vision through:
Analyzing every customer’s aims, objectives and purpose of research
Using advanced and latest tools and technique of research and analysis
Coordinating and including their own ideas and knowledge
Providing the desired inferences and results of the research
In the past decade, we have successfully assisted students from various universities in India and globally. We at Writekraft Research & Publications LLP head office in Kanpur, India are most trusted and professional Research, Writing, Guidance and Publication Service Provider for PhD. Our services meet all your PhD Admissions, Thesis Preparation and Research Paper Publication needs with highest regards for the quality you prefer.
Our Achievements
NATIONAL AWARD FOR BEST RESEARCH PROJECT (By Hon. President APJ Abdul Kalam)
GOLD MEDAL FOR RESEARCH ON DISABILITY (By Disabled’s Club of India)
NOMINATED FOR BEST MSME AWARDS 2017
5 STAR RATING ON GOOGLE
We have PhD experts from reputed institutions/ organizations like Indian Institute of Technology (IIT), Indian Institute of Management (IIM) and many more apex education institutions in India. Our works are tailored and drafted as per your requirements and are totally unique.
From past years our core advisory members, research team assisted research scholars from various universities from all corners of world.
PRESENT SCENARIO OF INDIAN PHARMACEUTICAL INDUSTRY IN VIEW OF GLOBAL ...sridivyaannavarapu
THE INDIAN GOVERNMENT HAS STARTED TO ENCOURAGE THE GROWTH OF DRUG MANUFACTURING BY INDIAN COMPANIES IN THE EARLY 1960s. AT PRESENT THERE ARE MANY NUMBER OF PHARMACEUTICAL COMPANIES IN INDIA WITH MANY NOVEL DRUG INVENTORIES
Present Status and Scope of Pharmaceutical industry in IndiaMadhuraNewrekar
The Indian pharmaceutical industry came into existence in 1901, when Bengal Chemical & Pharmaceutical Company started its maiden operation in Calcutta.
The next few decades saw the pharmaceutical industry moving through several phases, largely in accordance with government policies. The development, present status and scope of pharmaceutical industry in India.
Writekraft Research and Publications LLP was initially formed, informally, in 2006 by a group of scholars to help fellow students. Gradually, with several dissertations, thesis and assignments receiving acclaim and a good grade, Writekraft was officially founded in 2011 . Since its establishment, Writekraft Research & Publications LLP is Guiding and Mentoring PhD Scholars.
Our Mission
“To provide breakthrough research works to our clients through Perseverant efforts towards creativity and innovation”.
Vision
Writekraft endeavours to be the leading global research and publications company that will fulfil all research needs of our clients. We will achieve this vision through:
• Analyzing every customer’s aims, objectives and purpose of research
• Using advanced and latest tools and technique of research and analysis
• Coordinating and including their own ideas and knowledge
• Providing the desired inferences and results of the research
In the past decade, we have successfully assisted students from various universities in India and globally. We at Writekraft Research & Publications LLP head office in Kanpur, India are most trusted and professional Research, Writing, Guidance and Publication Service Provider for PhD. Our services meet all your PhD Admissions, Thesis Preparation and Research Paper Publication needs with highest regards for the quality you prefer.
Writekraft Research and Publications LLP was initially formed, informally, in 2006 by a group of scholars to help fellow students. Gradually, with several dissertations, thesis and assignments receiving acclaim and a good grade, Writekraft was officially founded in 2011 . Since its establishment, Writekraft Research & Publications LLP is Guiding and Mentoring PhD Scholars.
Our Mission
“To provide breakthrough research works to our clients through Perseverant efforts towards creativity and innovation”.
Vision
Writekraft endeavours to be the leading global research and publications company that will fulfil all research needs of our clients. We will achieve this vision through:
Analyzing every customer’s aims, objectives and purpose of research
Using advanced and latest tools and technique of research and analysis
Coordinating and including their own ideas and knowledge
Providing the desired inferences and results of the research
In the past decade, we have successfully assisted students from various universities in India and globally. We at Writekraft Research & Publications LLP head office in Kanpur, India are most trusted and professional Research, Writing, Guidance and Publication Service Provider for PhD. Our services meet all your PhD Admissions, Thesis Preparation and Research Paper Publication needs with highest regards for the quality you prefer.
Our Achievements
NATIONAL AWARD FOR BEST RESEARCH PROJECT (By Hon. President APJ Abdul Kalam)
GOLD MEDAL FOR RESEARCH ON DISABILITY (By Disabled’s Club of India)
NOMINATED FOR BEST MSME AWARDS 2017
5 STAR RATING ON GOOGLE
We have PhD experts from reputed institutions/ organizations like Indian Institute of Technology (IIT), Indian Institute of Management (IIM) and many more apex education institutions in India. Our works are tailored and drafted as per your requirements and are totally unique.
From past years our core advisory members, research team assisted research scholars from various universities from all corners of world.
Make In India – Healthcare Reforms, Insurance, Innovations, Investments & Inf...Indian Affairs
7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014
Friday, 26th December, Hotel Sahara Star, Mumbai, India
Make In India – Healthcare Reforms
Insurance,Innovations,Investments & Infrastructure
“Empowering India’s Developing Healthcare System”
Investing the Healthcare Solutions of Tomorrow in difficult Times
Make In India – Healthcare Reforms, Insurance, Innovations, Investmentspharmaleaders
7th Annual Pharmaceutical Leadership Summit & Pharmaleaders Business Leadership Awards 2014
Friday, 26th December, Hotel Sahara Star, Mumbai, India
Make In India – Healthcare Reforms
Insurance,Innovations,Investments & Infrastructure
“Empowering India’s Developing Healthcare System”
Investing the Healthcare Solutions of Tomorrow in difficult Times Theme Address : Make In India – Healthcare Reforms, Insurance, Innovations, Investments & Infrastructure.
Mr. Daara Patel, Secretary General, IDMA ( Indian Drug Manufacturers Association)
Evolution of the healthcare industry in India and the potential impact of the...Harshit Jain
2014 looks to be a positive but challenging year for the Indian health care sector; one in which many historic business models and operating processes will no longer suffice amid rising demand, continued cost pressures, lack of or inadequate care facilities, and rapidly evolving market conditions. India, likely will be dominated by the “Modi-care” –Health assurance for all.
Project on Production and Packaging in Pharmaceutical Industry Emcure By Nikh...Nikhil Dhawan
This is the Complete Project that I`ve Completed on 7/08/2014 and It is Now Brand New Project Report Suitable for Students doing MBA, PGDBM and Having Topics like Marketing or HR. No Ads, No Price, No Money!
You Can Contact Me for More Free Projects! Just Download the Project and Enjoy! Cheers!!
Best of Luck
Nikhil Dhawan
9018580277, 9622334428
nikdhawan@outlook.com.
contactnikhildhawan@gmail.com.
contact_nikhildhawan@gmail.com
Pharma Policy 2017 - Read it in MedicinMan September 2017 IssueAnup Soans
1. Draft Pharma Policy: The Good, The Bad and The Ugly...............................................1
Interview with Sunil Attavar
2. Career Brand Plan: A Career Stepping
Stone..........................................................9
Soham Wagh
3. Succeeding as Country GM at GSK: A Whitepaper..............................................12
Sundar Ramachandran
4. Role of Digital in the Customer Journey ....................................................................21
Salil Kallianpur
5. Executive Function Disorder .................24
Vivek Hattangadi
Indian pharmaceutical history began from Gupta period which was existed from approximately 320 to 550 CE where people were dependent only on indigenous form of medicine before British rule.
In India Allopathic medication was started in British rule, but production of such medicines was not in the country.
In 1901 Acharya P C Ray started first Indian Pharmaceutical Industry, Bangal Chemical in Calcutta.
The government started to encourage the growth of drug manufacturing by Indian companies in the early 1960s, and with the Patents Act in 1970.
However, economic Liberalization in 90s enabled the industry to become what it is today.
Status of pharmaceutical industry in indiaShadab Khan
Status of Pharmaceutical Industry in India
-History
-Evolution
-Current Scenario
-Market Share
-Government Initiatives
-Top 10 Pharmaceutical Industry
-R&D Spendings
-Challenges
-Road Ahead
May 2015 Edition of BEACON, A Monthly Newsletter by SIMCON.
Inside this issue:
About Us
Our Team
INDUSTRY ANALYSIS : Pharmaceutical Industry
COMPANY ANALYSIS : Sun Pharma
BRAND ANALYSIS : Kellogg's
Concept of the month
Similar to Entrepreneurial Challenges in Indian Pharmaceutical Sector (2) (20)
Entrepreneurial Challenges in Indian Pharmaceutical Sector (2)
1. Entrepreneurial Challenges in
Indian Pharmaceutical Sector
Presented by:
Ms. Disha Manik
Ms. Abhilasha Singh
H. & G. H. Mansukhani Institute of Management
3. Entrepreneurship is a process of
creating something different, with
value, by devoting necessary time
and effort, by assuming the
accompanying financial,
psychological, and social risks, and
receiving the resulting rewards of
monetary and personal satisfaction
(Bowen and Hisrich, 1986).
4. 4
An Entrepreneur…
…is an innovator who combines technical
innovations and financial finesses.
…plays an important role in producing
competitive products, processes, and
services.
…generates new employment.
…develops local and regional areas.
5. Many entrepreneurial ventures start with a
dream, but it takes more than just a dream
for them to grow into successful These
ventures take time, effort, and energy and
a host of other challenges…
8. Pharmaceutical market in India is
ranked 3rd globally in terms of
volume and 13th in terms of value,
accounting for about 10% of the
world's production by volume.
9. There are approximately 250
large units and about 8000 Small
Scale Units, which form the core
of the pharmaceutical industry in
India (including 5 Central Public
Sector Units).
13. Effects of new product patent
Regulatory reforms
Quality management
Conformance to global standards
Pricing Issues
R & D Spending
Information Technology
15. • The Patents Amendment Act, 2005, introduced
"Product Patent" in India.
• The product patent was granted for the new
product for a period of twenty years.
• Earlier due to absence of product patent, only
process patents were granted for a new process of
manufacturing an already known product or for
manufacturing a new product.
• This has helped Indian pharmaceutical industry to
develop generic versions of the new medical drugs
without having fear of infringement of patent.
16. But now, product patents regime means,
that Indian generic drugs manufacturers
can no longer manufacture drugs by
reverse engineering till the time patent is in
force.
Thus, earlier the Indian pharmaceutical
industries produced generic drugs on mass
level by using the process of reverse
engineering.
Due to the low per capita income the Indian
people may not be able to afford the
escalated costs of new entrant drugs
developed by the Pharmaceutical giants.
This also threatens the supply of generic
drugs to the heavily dependent countries
along with the domestic market. Thus, this
could effect the profitability of the
companies.
18. 1
• MIDC
2
• Maharashtra Pollution
Control Board
(MPCB),
3
• MSEB
4
• FDA
5
• CIDCO/ Drug
Controller General
(India) (DCGI),
6
• Excise-State and
Central
A) Any entrepreneur, on a monthly/yearly basis, has
deal with government/non government agencies like
7
• Sales tax
8
• Customs and port
9
• Local political partie
10
• Transportation local
body
11
• Income tax
19. On an average, even if one department takes one
week’s time for settling any issue, around 20 weeks
out of 52 weeks a year are spent by an entrepreneur
20. (B) SEZ vs. Non-SEZ
Normally the
process of
setting up a
plant is simpler
in SEZ but very
difficult in non-
SEZ.
Difficulties are
faced in getting
no-objection
certificates
(NOCs) and
other clearances
from the
Pollution Control
Board for units
and other
related activities
in non-SEZ
zones.
Even getting
environment
clearance from
the Ministry of
Environment
and Forest is a
challenge.
Permissions are
required for
adequate water
and electricity
supply as well.
Getting FDA
licenses are too
difficult in such
non-SEZs
22. “We are taking swift action to
prevent substandard quality
products from reaching US
consumers”
- US FDA
23. All the four plants of Ranbaxy have been
banned by FDA.
Toansa
Paonta
Sahib
Dewas Mohali
24. Karkhadi and Halol unit of Sunpharma
banned for not adopting good
manufacturing practices and for some
data integrity issues.
25. Pricing Issues
• To ensure that vital drugs are available
at affordable prices, the Government
exercises control over the prices of
certain drugs it defines as ‘essential’.
• The Drug Pricing Policy 2013 provides
the framework through which ceiling
prices for these essential drugs are
worked out.
• These price limits are given effect by
passing the order referred to as the
DPCO.
26. • Under the earlier avatar of the
DPCO (1995), 74 drugs were
subject to price control.
• In the 2013 version, the number of
drugs under the price control was
expanded five-fold to 348.
• Thus, this gives less scope to the
companies to invest in R&D.
27. R & D Spending
Indian
manufacturer
s cannot
fulfill their
ambitions to
become
players on
the world
stage unless
they make
significant
increases to
their R&D
expenditures
at 2 percent
of sales.
These are
currently far
below the
global level
of 10 to 20
percent.
To promote
R&D in SMEs,
the
government
needs to
come up with
incentives
and
promotion
programmes.
At present,
the
government
is providing
tax deduction
to promote
R&D, but
according to
industry
experts, this
is not
sufficient.
28. Information TechnologyInformationTechnology
One of the main
challenges
faced by
pharma
companies is
the
implementation
of Information
Technology (IT)
tools at an
affordable cost.
InformationTechnology
Software tools
would help
SMEs in
computer-aided
drug designing.
InformationTechnology
But most
players continue
to under-invest
in IT systems
and good
accounting
practices due to
its high cost.
29. Other Challenges..
Unwarranted political interference and gundaraj at the
local level
The Ministry of Labor takes care of labor welfare.
There is no entrepreneur welfare programme.
Increasing competition from other low cost nations
Little or no global exposure